peter attia paul grewal covid-19

AMA #30: How To Read And Understand Scientific Studies| The Drive with Peter Attia #188

Check out The Drive episode page

Key Takeaways

  • It’s a valuable skill to be able to sift through the noise and find the signal in scientific studies
  • Though meta-analyses summarize findings from previous studies, it’s still prudent to look at each individual study to make sure they’re sound – garbage in, garbage out (and vice versa)
  • Observational studies are non-intervention studies looking at the outcomes of people and data to find patterns
  • Experimental studies are intervention studies to determine safety and efficacy between groups of people assigned to intervention or control (non-intervention)
  • The gold standard of experimental studies is a randomized controlled trial, ideally, double-blind so neither participant nor researcher knows who is assigned to intervention or control
  • While clinical trials are regulated by FDA, most of the world follows the same guidelines for Phases I – IV

Introduction

In this special episode of The Drive, Peter Attia sits down with Head of Research at Attia Medical, PC Bob Kaplan (@bobkaplan) to take a deep dive into reading & understanding studies. Attia highlights how to find the important points, defines various types of studies, the evolution of studies from idea to execution, and much more. Note, this is only a preview. The full episode is only available to subscribers.

Host: Peter Attia (@PeterAttiaMD)

How Does A Study Go From Idea To Execution

  • Good science is hypothesis-driven
  • Studies are often guided by the null hypothesis versus the alternative hypothesis
    • Null hypothesis: there is no relationship between two phenomena
    • Alternative hypothesis: there is a relationship between the phenomena
  • The gold standard to test the hypothesis is an experimental design, randomized controlled trial – ideally, be double-blinded

Different Types Of Studies

  • Study design can be broken down into a few categories: (1) observational studies; (2) experimental studies; (3) meta-analysis or review
  • Observational studies – no intervention, just looking at data and people to find patterns
    • Individual case report: dive into one specific patient case that is driven by an observation that has not been studied before and can inform future treatment
    • Case studies: similar to individual case reports but with a larger set of patients
    • Retrospective cohort study: observational (not intervention) look back at a set of people who took part in ‘x’ and see how they are doing today versus people who did not take part in ‘x’
    • The goal of cohort studies is to establish a pattern and potentially determine casualty
    • Prospective cohort study: follow people who use ‘x’ over the next 5-10 years and compare them to people who do not use ‘x’ and observe outcomes
  • Experimental studies – intervention
    • Non-randomized trial (AKA open-label trial): two groups of people either given placebo or intervention but not randomized; grouping people based on certain characteristics
      • Comes with a lot of bias because there is a reason you put certain people in a group
      • Patients can also self-select into this type of study
    • Randomized controlled trial: the gold standard of experimental design; study the question but take bias out by randomly assigning people to treatment or control group
  • Meta-analyses: combine data from multiple studies that are attempting to look at the same question
    • This seems great on the surface but is highly dependent on the quality of the original studies: garbage in, garbage out – and vice versa
    • You can gain great insight from meta-analyses but take a closer look and examine each of the studies within the analyses

Phases Of Clinical Trials

  • FDA clinical trials: drug or therapeutic you think will have some benefit in humans after showing success in animal models
  • The first step is to file an investigational new drug (IND) application showing pre-clinical work and setting an intention to study in humans
  • Phase I: small studies to determine toxicity (not whether the drug works) in a range of doses with efficacy
  • Phase I studies look to see whether drug hurts, not how well it works
  • Phase II: evaluate the safety and start exploring efficacy through open-label, usually non-randomized design
  • Phase II studies are small and will compare to the natural history of patient outcomes to start examining the efficacy
  • The goal is to randomize Phase II but patients will often self-select or doctors will recommend
  • If drug or therapeutic has been deemed safe enough for use and has some efficacy, it will move on to Phase III
  • Phase III: huge step up from Phase II studies; this is a randomized controlled trial and ideally blinded with the goal of measuring efficacy and determining broad use
  • Phase IV: post-marketing study after the drug has been approved and uses information from a broader audience and exploring potential off-label uses or additional side effects

To learn more: subscribe and/or read Peter Attia’s series, Studying Studies.

Drive with Dr. Peter Attia : , , ,
Notes By Maryann

More Notes on these topics

Top Insights and Tactics From

31 Best Podcasts of All Time

FREE when you join over 25,000 subscribers to the
Podcast Notes newsletter

No Thanks